Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer

BACKGROUND: Gemcitabine plus nab-paclitaxel (GA) and modified FOLFIRINOX (FFX) have been widely used as standard first-line treatment in pancreatic cancer. However, it is unclear which regimen is more efficacious. AIM: To evaluate a retrospective analysis comparing the efficacy and safety of FFX and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Clin Cases
Main Authors: Han, Sung Yong, Kim, Dong Uk, Seol, Young Mi, Kim, Suk, Lee, Nam Kyung, Hong, Seung Baek, Seo, Hyung-Il
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2020
Fag:
Retrospective Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479547/
https://ncbi.nlm.nih.gov/pubmed/32953848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i17.3718
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker